- BioPharm International-10-15-2020
- Volume 2020 eBook
- Issue 3
Tackling Cybersecurity Challenges in Legacy Systems
Ongoing and emerging cyber-risks to legacy operational technology systems in bio/pharmaceutical manufacturing must be addressed.
As bio/pharma manufacturers make their operations and networks increasingly streamlined and interconnected, there is a need to connect older facilities to the supply chain. In turn, this means that operational technology (OT) cybersecurity measures must be introduced to legacy systems to support archaic equipment, older operating systems, and decades-old protocols as well as networks where it is not possible to fully monitor the operational network or to detect and control intrusions.
Article Details
BioPharm International
eBook: Regulatory Sourcebook, October 2020
October 2020
Pages: 28–30
Citation
When referring to this article, please cite it as R. Brokamp and A. Karisik, “Tackling Cybersecurity Challenges in Legacy Systems," BioPharm International Regulatory Sourcebook (October 2020).
Articles in this issue
almost 5 years ago
Bio/Pharma Industry Works Overtime to Find COVID-19 Therapiesalmost 5 years ago
GMPs Guide COVID-19 Vaccine Manufacturingalmost 5 years ago
Viral Vector API Characterization of Product-Related Impuritiesalmost 5 years ago
Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?almost 5 years ago
Enhancing Process Validation for Sterile Liquid and Freeze-Dried Formsalmost 5 years ago
Due Diligence Assessment of CMC Activitiesalmost 5 years ago
Strong Quality Culture: A How-To for Busy Managersalmost 5 years ago
Resources, Guidelines, and Guidance Documentsalmost 5 years ago
Regulatory and Standard Setting OrganizationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
